Introduction

Hepatitis B virus (HBV) possesses one of the smallest known genomes among human DNA viruses, yet it encodes a highly sophisticated replication system.

The HBV genome is approximately:

It is:

• Circular

• Partially double-stranded

• Highly compact

• Rich in overlapping open reading frames (ORFs)

• Associated with a terminally protein-linked viral DNA strand

• Replicated through an RNA intermediate

The mature viral genome inside the Dane particle is called:

Relaxed circular DNA — rcDNA

After the virus enters the hepatocyte, rcDNA is transported to the nucleus and repaired to form:

Covalently closed circular DNA — cccDNA

cccDNA is the transcriptional template responsible for production of viral RNAs.

1. Basic Characteristics of the HBV Genome

2. Why Is the HBV Genome Called “Partially Double-Stranded”?

Unlike a conventional fully double-stranded DNA genome, HBV DNA contains:

A nearly complete negative strand

and

An incomplete positive strand

Therefore, the genome is:

This distinctive structure is called:

Relaxed circular DNA (rcDNA)

The plus strand is variable in length and does not completely cover the negative strand.

3. Structure of the Mature HBV Genome

The mature virion contains:

• Circular DNA

• Complete negative strand

• Incomplete positive strand

• Polymerase covalently attached to the 5′ end of the negative strand

• Short RNA primer associated with the positive-strand DNA

This unusual architecture is a direct consequence of the mechanism by which HBV reverse-transcribes its genome.

4. The HBV Genome Is Extremely Compact

The most remarkable feature of the HBV genome is:

The four major ORFs are:

1. S ORF

2. C ORF

3. P ORF

4. X ORF

These ORFs overlap extensively.

This allows a genome of only approximately 3.2 kb to encode:

• Surface proteins

• Core protein

• HBeAg

• Polymerase

• HBx

and multiple regulatory elements.

5. Major HBV Open Reading Frames

The four major ORFs can be summarized as:

The precore region is part of the C-region transcriptional organization, rather than being considered a completely separate major ORF.

6. S Gene / Surface ORF

The S gene encodes the three major HBV envelope proteins:

• Large surface protein

• Middle surface protein

• Small surface protein

These are produced from different translation initiation sites within the surface gene.

The surface gene contains three regions:

pre-S1

pre-S2

S

7. Large Surface Protein

The large surface protein is:

L-HBs

It contains:

pre-S1 + pre-S2 + S

The pre-S1 domain is particularly important for:

• Hepatocyte attachment

• NTCP interaction

• Viral entry

• Hepatotropism

The pre-S1 region is also myristoylated, which is important for infectivity.

8. Middle Surface Protein

The middle surface protein is:

M-HBs

It contains:

pre-S2 + S

It contributes to the viral envelope and particle assembly.

9. Small Surface Protein

The small surface protein is:

S-HBs

It contains:

S

It is the most abundant surface protein and constitutes the major component of circulating HBsAg.

10. The Surface Gene and HBsAg

The clinical marker:

HBsAg

represents HBV surface proteins circulating in blood.

Most circulating HBsAg does not necessarily represent complete infectious virions.

Large quantities are released as:

• Spherical particles

• Filamentous particles

These are non-infectious subviral particles.

11. Precore/Core Region

The C ORF produces the core protein:

HBcAg

which forms the viral nucleocapsid.

An upstream precore region permits production of the precursor of:

HBeAg

HBeAg is secreted and is structurally distinct from the capsid-forming HBcAg.

12. HBcAg

HBcAg is the:

Hepatitis B core antigen

Its major functions include:

• Capsid assembly

• Genome packaging

• Interaction with polymerase

• Organization of intracellular replication intermediates

The core protein is therefore essential for HBV replication.

13. HBeAg and the Precore Region

HBeAg originates from the precore/core region.

The precore sequence directs the precursor protein toward the secretory pathway.

The precursor is processed to produce the secreted HBeAg.

Therefore:

HBcAg

is primarily a structural capsid protein.

HBeAg

is a secreted viral protein.

They arise from closely related genomic regions but have different biological roles.

14. P Gene — The Polymerase ORF

The P ORF encodes the HBV polymerase.

It is the largest ORF in the HBV genome.

The polymerase is responsible for the unusual replication mechanism of HBV.

It possesses several functional domains:

1. Terminal protein domain

2. Spacer domain

3. Reverse transcriptase/DNA polymerase domain

4. RNase H domain

15. Terminal Protein Domain

The terminal protein domain has an unusual function:

The polymerase becomes covalently linked to the newly synthesized negative DNA strand.

This is one reason the mature HBV genome has polymerase attached to its DNA.

16. Spacer Domain

Between the terminal protein and reverse transcriptase regions lies a relatively flexible:

Spacer domain

It has less direct enzymatic activity than the other polymerase domains but contributes to polymerase structure and function.

Its relative tolerance for sequence variation also contributes to HBV genetic diversity.

17. Reverse Transcriptase Domain

The reverse transcriptase domain performs:

RNA → DNA synthesis

The viral polymerase uses:

Pregenomic RNA (pgRNA)

as the template for synthesis of the viral DNA genome.

This is the defining molecular feature of HBV replication.

18. RNase H Domain

The RNase H domain degrades the RNA strand of RNA-DNA hybrids generated during reverse transcription.

Therefore, the HBV polymerase is multifunctional:

19. X Gene

The fourth major ORF is:

X

It encodes:

HBx protein

HBx is a relatively small regulatory protein.

It is not considered a major structural component of the mature Dane particle.

HBx influences several host cellular pathways involving:

• Transcription

• Signal transduction

• Cell-cycle control

• DNA damage response

• Mitochondrial function

• Epigenetic regulation

HBx is also implicated in HBV-associated hepatocarcinogenesis.

20. HBV Genome — Simplified Map

                    HBV GENOME (~3.2 kb)

                         C / Pre-C
                      ┌─────────────┐
                      │ Core/HBeAg  │
                      └─────────────┘

       X ────────────────────────────────┐
                                         │
                                         │
       S / Pre-S1 / Pre-S2 ──────────────┤
                                         │
                                         │
       P / Polymerase ───────────────────┘

     Extensive overlap between ORFs

The four major coding regions are not arranged as independent non-overlapping genes.

21. HBV Genome and Overlapping ORFs

This is one of the most important molecular characteristics of HBV.

The polymerase gene overlaps extensively with:

• Surface gene

• Core region

• X region

Consequently, a nucleotide substitution may potentially affect more than one protein.

This has major clinical implications.

22. Why Overlapping Genes Matter

A single nucleotide mutation can potentially produce:

Polymerase mutation

and simultaneously:

Surface protein mutation

Therefore, antiviral drug resistance mutations in polymerase may sometimes alter the corresponding overlapping surface antigen.

This can potentially influence:

• Antigenicity

• Immune recognition

• Vaccine escape

• Diagnostic detection

Thus:

23. HBV Regulatory Elements

Although the HBV genome is extremely small, it contains several important regulatory regions.

Important elements include:

• Enhancer I

• Enhancer II

• Core promoter

• Basal core promoter

• Pre-S1 promoter

• S promoter

• X promoter

• Polyadenylation signal

• ε (epsilon) packaging signal

• Direct repeat regions

These regulate transcription, RNA processing and genome replication.

24. Enhancer I

Enhancer I is an important regulatory element involved in transcriptional regulation.

It contributes to:

• Viral gene expression

• Tissue specificity

• Regulation of viral RNA synthesis

Its activity contributes to the preferential replication of HBV in hepatocytes.

25. Enhancer II

Enhancer II lies in the pre-S/S and core-associated genomic region.

It contributes to regulation of HBV transcription.

Together, the enhancer regions help HBV achieve efficient transcription from the compact genome.

26. Core Promoter

The core promoter regulates transcription of:

• Pregenomic RNA

• Precore RNA

Therefore it has major effects on:

• Core protein production

• Polymerase production

• Genome replication

• HBeAg production

Mutations within this region can significantly alter the HBV replication phenotype.

27. Basal Core Promoter

The:

Basal core promoter (BCP)

is particularly important clinically.

Certain mutations can:

• Reduce HBeAg production

• Alter HBV replication

• Contribute to HBeAg-negative disease

A commonly discussed mutation pattern is:

A1762T/G1764A

These mutations can alter transcriptional regulation of the precore/core region.

28. Precore Mutations

Precore mutations can prevent or substantially reduce production of HBeAg.

A classic mutation is:

G1896A

This can create a premature stop codon in the precore coding sequence.

The result may be:

HBeAg negative

despite:

ongoing HBV replication

Therefore:

HBV DNA and ALT must be interpreted together with serology and clinical context.

29. ε (Epsilon) Packaging Signal

One of the most important cis-acting elements in HBV replication is:

ε (epsilon)

It is a stem-loop structure located near the 5′ end of the pgRNA.

The viral polymerase recognizes ε.

The interaction between:

Polymerase + ε

is essential for:

• pgRNA encapsidation

• Initiation of reverse transcription

This is a fundamental molecular step in HBV replication.

30. Pregenomic RNA

The:

Pregenomic RNA (pgRNA)

has a central role in HBV biology.

It serves as:

1. mRNA

for synthesis of:

• Core protein

• Polymerase

and:

2. Template

for reverse transcription.

Thus:

31. Direct Repeat Sequences

HBV contains important repeated sequences:

DR1

and

DR2

These are short direct repeat sequences involved in the mechanism of reverse transcription and circularization of the newly synthesized DNA genome.

They are essential to understanding how a linear DNA intermediate is ultimately converted into the characteristic relaxed circular DNA genome.

32. HBV Reverse Transcription — Genome Perspective

The replication sequence can be simplified as:

cccDNA

↓

pgRNA

↓

Encapsidation

↓

Minus-strand DNA synthesis

↓

RNA degradation

↓

Plus-strand DNA synthesis

↓

rcDNA

↓

Envelopment

↓

Mature virion

This is why HBV is classified as a DNA virus with a reverse-transcription replication strategy.

33. Formation of the Negative DNA Strand

Within the nucleocapsid:

1. Polymerase binds ε on pgRNA.

2. Polymerase becomes activated.

3. A short DNA primer is initiated.

4. Minus-strand DNA synthesis proceeds using pgRNA as template.

5. RNase H degrades the RNA template.

The resulting minus strand is essentially complete.

34. Formation of the Positive DNA Strand

The remaining RNA fragment provides the primer for positive-strand DNA synthesis.

The polymerase then synthesizes the plus strand.

However, synthesis is incomplete when the mature virion is released.

Therefore:

35. Why Is the Genome Circular?

The circular architecture is generated through the unique reverse-transcription mechanism involving:

• Terminal redundancy

• Direct repeats

• Template switching

• Strand transfer

These molecular events eventually establish the characteristic relaxed circular DNA genome.

36. rcDNA → cccDNA

When HBV infects a hepatocyte, the incoming rcDNA is transported to the nucleus.

Host DNA repair machinery converts it into:

Covalently closed circular DNA

or:

cccDNA

This is one of the most important steps in HBV biology.

37. cccDNA Structure

cccDNA is:

• Circular

• Fully double-stranded

• Covalently closed

• Located in the nucleus

• Associated with host histones and other proteins

It behaves like a small episomal chromatinized DNA minichromosome.

38. Why cccDNA Matters

cccDNA functions as the transcriptional template for:

• pgRNA

• Precore RNA

• Surface RNAs

• X-related transcripts

Because cccDNA can persist in hepatocyte nuclei, it represents an important reservoir for viral persistence.

This is a major reason why:

39. Integrated HBV DNA vs cccDNA

These two concepts must not be confused.

cccDNA

• Episomal

• Nuclear

• Transcriptionally active reservoir

• Central to productive HBV replication

Integrated HBV DNA

• Inserted into host chromosomes

• Generally not responsible for producing complete infectious virions

• Can contribute to altered host gene expression and hepatocarcinogenesis

• Can contribute to production of some viral proteins, particularly HBsAg in certain contexts

This distinction is clinically important.

40. HBV Genome and Hepatocellular Carcinoma

HBV DNA integration can occur during chronic infection.

Integration can result in:

• Genomic instability

• Insertional effects

• Altered host gene regulation

• Chromosomal abnormalities

HBx-related mechanisms and integration together contribute to the carcinogenic potential of HBV.

Importantly, HBV-associated HCC can occur even without advanced cirrhosis in some patients.

41. Genetic Diversity of HBV

HBV exists in infected individuals as a population of genetically related variants often described as a:

Quasispecies

This occurs because reverse transcription is relatively error-prone and HBV lacks the proofreading capability characteristic of many high-fidelity DNA polymerases.

Consequently:

• Mutations arise frequently.

• Variants may be selected by immune pressure.

• Antiviral therapy can select resistant variants.

• Different genotypes and subgenotypes exist.

42. HBV Genotypes

HBV is classified into multiple genotypes based on genome-wide sequence divergence.

The classical genotypes are:

A, B, C, D, E, F, G, H, I and J

Genotype distribution varies geographically.

Genotypes can differ in:

• Geographic distribution

• Natural history

• HBeAg seroconversion patterns

• Risk of cirrhosis

• HCC risk

• Treatment response in some settings

However, genotype alone should not be used to determine management.

43. HBV Genotype and Clinical Disease

Certain genotype-associated patterns have been described.

For example:

Genotype C

Has been associated in several populations with:

• Later HBeAg seroconversion

• Higher risk of progressive liver disease

• Increased HCC risk compared with some other genotypes

Genotype B

In some Asian populations has been associated with earlier HBeAg seroconversion and differing HCC patterns.

Genotype D

Is highly prevalent in parts of:

• India

• Mediterranean region

• Middle East

However, individual patient management requires integration of:

HBV DNA + ALT + fibrosis + clinical status + HBeAg + treatment history

rather than genotype alone.

44. HBV Genotype vs Serotype

These terms are different.

Genotype

Based on:

Nucleotide sequence differences

Serotype

Based primarily on:

Antigenic determinants of HBsAg

Historically recognized serological subtypes include:

• adw

• adr

• ayw

• ayr

The determinants are related mainly to amino acid variation in the surface antigen.

45. “a” Determinant

A particularly important region of HBsAg is the:

Major hydrophilic region (MHR)

Within it lies the:

“a” determinant

The “a” determinant is highly important because it is:

• A major target of neutralizing antibodies

• Important for vaccine-induced immunity

• Important for serological detection

Mutations in this region can produce:

Immune escape variants

or:

Diagnostic escape variants

46. Surface Gene Mutants

Mutations in the surface gene may affect:

• Antibody recognition

• Vaccine effectiveness

• HBsAg detection

• Viral fitness

A famous example is the:

G145R mutation

in the surface antigen.

It has historically been associated with an immune escape phenotype.

However, the clinical significance of individual surface mutations varies according to the viral and host context.

47. Polymerase Mutations

Mutations in the polymerase gene can result in:

Antiviral resistance

Examples include resistance-associated substitutions involving the reverse transcriptase domain.

Because the polymerase gene overlaps the S gene, some polymerase substitutions can produce corresponding changes in HBsAg.

This is a direct consequence of HBV's compact genome.

48. Why HBV Genome Organization Is Clinically Important

HBV provides a remarkable example of how molecular genetics translates directly into clinical medicine.

Genome overlap

↓

Polymerase mutation

↓

Possible surface mutation

↓

Drug resistance + altered antigenicity

Similarly:

Precore mutation

↓

Reduced HBeAg production

↓

HBeAg-negative replicating HBV

And:

cccDNA persistence

↓

Long-term viral reservoir

↓

Difficulty achieving complete cure

49. HBV Genome — Diagnostic Correlations

This makes the genome map clinically useful rather than merely theoretical.

50. HBV Genome and Antiviral Targets

The most important direct antiviral target is:

Polymerase/reverse transcriptase

Nucleos(t)ide analogues interfere with viral DNA synthesis.

Major modern agents include:

• Tenofovir disoproxil fumarate

• Tenofovir alafenamide

• Entecavir

The fact that these drugs suppress DNA synthesis but do not directly eradicate cccDNA explains why prolonged therapy may be required.

51. Why HBV Is Difficult to Cure

Three biological features are especially important:

1. cccDNA

Persistent nuclear reservoir.

2. Integrated HBV DNA

Can persist independently of productive replication.

3. Long-lived infected hepatocytes

Even when serum HBV DNA becomes undetectable, infected hepatocytes may remain.

Therefore:

52. Complete HBV Genome — High-Yield Map

                         HBV GENOME
                         ~3.2 kb

                  ┌──────────────────┐
                  │     S REGION     │
                  │                  │
                  │ pre-S1 | pre-S2 | S
                  │                  │
                  │ L-HBs | M-HBs | S-HBs
                  └──────────────────┘

          ┌───────────────────────────────┐
          │       C / PRE-C REGION        │
          │                               │
          │       HBcAg + HBeAg           │
          └───────────────────────────────┘

          ┌───────────────────────────────┐
          │          P REGION             │
          │                               │
          │ TP | Spacer | RT | RNase H    │
          │                               │
          │        POLYMERASE             │
          └───────────────────────────────┘

                    ┌─────────┐
                    │ X REGION│
                    │   HBx   │
                    └─────────┘

        Extensive ORF overlap throughout genome

53. The Five Most Important HBV Genome Concepts

If you remember only five concepts, remember these:

1. ~3.2 kb

HBV has a tiny genome.

2. Four major ORFs

S + C + P + X

3. Extensive overlap

The genes overlap extensively.

4. Reverse transcription

pgRNA → DNA

5. cccDNA

rcDNA → cccDNA

and cccDNA acts as the nuclear transcriptional reservoir.

54. Examination Pearls

Pearl 1

HBV is a:

DNA virus with reverse transcription

Pearl 2

Mature HBV genome:

Relaxed circular partially dsDNA

Pearl 3

Nuclear transcription template:

cccDNA

Pearl 4

Largest ORF:

P gene

Pearl 5

P gene encodes:

Polymerase

Pearl 6

Surface proteins:

L, M and S

Pearl 7

L-HBs:

pre-S1 + pre-S2 + S

Pearl 8

M-HBs:

pre-S2 + S

Pearl 9

S-HBs:

S

Pearl 10

Core:

HBcAg

Pearl 11

Secreted precore-associated antigen:

HBeAg

Pearl 12

Important packaging signal:

ε (epsilon)

Pearl 13

Important repeated sequences:

DR1 and DR2

Pearl 14

Important entry receptor:

NTCP

Pearl 15

Important surface immune target:

“a” determinant

Pearl 16

Classic surface immune escape mutation:

G145R

Pearl 17

Classic precore mutation:

G1896A

Pearl 18

Classic basal core promoter mutations:

A1762T/G1764A

Pearl 19

Major nuclear reservoir:

cccDNA

Pearl 20

Major replication enzyme:

HBV polymerase

55. Final Conceptual Summary

The HBV genome is a remarkable example of genetic economy.

A genome of only approximately 3.2 kb simultaneously encodes:

• Three envelope proteins

• Core protein

• HBeAg

• Polymerase

• HBx

It achieves this through:

Overlapping ORFs + alternative initiation sites + compact regulatory architecture

The genome also encodes the machinery necessary for an unusual replication pathway:

rcDNA

↓

cccDNA

↓

viral RNA

↓

pgRNA

↓

reverse transcription

↓

rcDNA

This cycle allows HBV to maintain a persistent nuclear reservoir and explains both its biological success and the difficulty of achieving complete eradication with currently available therapies.

The most clinically important molecular relationships are:

Understanding these five relationships provides the molecular foundation for essentially every subsequent HBV topic.

Standard References

1. Knipe DM, Howley PM, editors. Fields Virology. Wolters Kluwer.

2. Flint SJ, Enquist LW, Racaniello VR, Rall GF. Principles of Virology. ASM Press.

3. Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. Elsevier.

4. Brooks GF, Carroll KC, Butel JS, Morse SA, Mietzner TA. Jawetz, Melnick & Adelberg's Medical Microbiology. McGraw-Hill.

5. Ryan KJ, Ray CG. Sherris Medical Microbiology. McGraw-Hill.

6. Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier.

7. Seeger C, Mason WS. Hepatitis B virus biology. Microbiology and Molecular Biology Reviews.

8. Ganem D, Prince AM. Hepatitis B virus infection — natural history and clinical consequences. New England Journal of Medicine.

9. Locarnini S, Zoulim F. Molecular genetics of HBV and antiviral resistance. Antiviral Therapy.

10. World Health Organization. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. WHO, 2024.

11. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on hepatitis B virus infection.

12. Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD guidance.

13. Yan H, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife. 2012.

14. Seeger C, Zoulim F, Mason WS. Hepadnaviruses. In: Fields Virology. Wolters Kluwer.

15. Revill PA, et al. A global scientific strategy to cure hepatitis B. The Lancet Gastroenterology & Hepatology.